NASDAQ · LFST

LifeStance Health Group, Inc.

$10.88 -$0.02 (-0.18%) 1D After hours

Key Metrics

$4.16B
Market cap
179.42×
P/E · TTM
$1.49B
Revenue · TTM
$23.20M
Net income
EPS · TTM $0.06
Dividend yield
Free cash flow $142.63M
Beta · 1Y 0.85
EBITDA · TTM $75.29M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 8
    The stock moved -13.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 8
  • May 7
    The stock moved +20.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$4.16B
Enterprise value$4.25B
Shares outstanding381.8M
52-wk range$3.74 – $11.76
Avg volume · 20D1.5M
Net cash −$85.79M
Book value / share$3.78
IndustryServices-Health Services
ExchangeNASDAQ
About LifeStance Health Group, Inc.
IPO dateJun 10, 2021
Employees8349

LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E179.42
P/S2.78
P/FCF29.18
EV/EBITDA56.42
EV/Sales2.84
Graham №$2.25

Profitability

Gross
Operating 2.2%
Net 1.6%
FCF 9.5%
ROE / ROIC 1.6% · 1.5%

Financial Health

Current ratio1.48
Quick ratio
Debt / equity0.19
Debt / EBITDA 3.73
Net cash −$85.79M
Working capital$116.18M

Cash Flow · TTM

Operating CF $182.35M
Capex −$39.72M
Free cash flow $142.63M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

7 / 9
Strong fundamentals · 7 of 9 signals passing

Altman Z-Score

4.0
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$2.25 vs $10.88
Trades 4.8× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings